Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication-Reference-Cited by-同舟云学术

Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication

Published:2022-12-28 Issue:7 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Kumar Prashant¹,Bird Christopher¹,Holland David¹,Joshi Sangeeta B.¹,Volkin David B.¹

Affiliation:

1. Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA

Funder

Bill & Melinda Gates Foundation

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2154100

Reference152 articles.

1. CDC. History of polio. Global immunization. 2021 [accessed 2022 Mar 4]. https://www.cdc.gov/polio/what-is-polio/index.htm#:~:text=Polio%2C%20or%20poliomyelitis%2C%20is%20a,move%20parts%20of%20the%20body.

2. One hundred years of poliovirus pathogenesis

3. The polio endgame

4. Franklin Delano Roosevelt: A Famous Patient

5. Poliovirus biology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Persistence following Primary Immunization and the Immunogenicity and Safety of a Booster Dose of a Multidose Sabin Strain-Based Inactivated Polio Vaccine in Infants Aged 18 Months;Vaccines;2024-01-25

2. Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?;Frontiers in Public Health;2024-01-08

3. mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions;Vaccines;2023-11-21

4. Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines;Vaccine;2023-10

5. Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate;Molecular Therapy - Methods & Clinical Development;2023-09